Evermay Wealth Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$757K Sell
3,541
-33
-0.9% -$7.38K 0.08% 102
2025
Q4
$612K Sell
3,574
-58
-2% -$9.02K 0.07% 114
2025
Q3
$487K Hold
3,632
0.06% 126
2025
Q2
$354K Buy
3,632
+1,292
+55% +$102K 0.04% 148
2025
Q1
$170K Hold
2,340
0.02% 204
2024
Q4
$169K Hold
2,340
0.03% 206
2024
Q3
$191K Hold
2,340
0.03% 202
2024
Q2
$249K Hold
2,340
0.04% 175
2024
Q1
$228K Sell
2,340
-10
-0.4% -$880 0.03% 188
2023
Q4
$184K Buy
2,350
+10
+0.4% +$682 0.03% 187
2023
Q3
$147K Buy
2,340
+180
+8% +$11.8K 0.03% 196
2023
Q2
$139K Hold
2,160
0.03% 211
2023
Q1
$115K Buy
2,160
+320
+17% +$15.7K 0.02% 223
2022
Q4
$77.5K Hold
1,840
0.02% 254
2022
Q3
$68K Hold
1,840
0.01% 254
2022
Q2
$79K Sell
1,840
-300
-14% -$14.3K 0.02% 236
2022
Q1
$115K Hold
2,140
0.02% 243
2021
Q4
$154K Buy
2,140
+1,090
+104% +$68.3K 0.03% 189
2021
Q3
$60K Hold
1,050
0.01% 249
2021
Q2
$68K Buy
+1,050
New +$66.3K 0.01% 252

Other funds holding LRCX

Evermay Wealth Management's LRCX Position: Q1 2026 in Review

Evermay Wealth Management reduced its Lam Research (LRCX) stake by 0.92% in Q1 2026, selling an estimated $7.38K and leaving 3,541 shares worth $757K. The position accounts for 0.08% of the portfolio, ranked #102.

Evermay Wealth Management first reported a position in LRCX in Q2 2021 and has held it in 20 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Evermay Wealth Management held 3,541 shares of Lam Research worth $757K as of Q1 2026.
  • Evermay Wealth Management sold 33 Lam Research shares in Q1 2026, an estimated $7.38K.
  • Lam Research made up 0.08% of Evermay Wealth Management's portfolio in Q1 2026, its #102 holding.
  • Evermay Wealth Management first reported a position in Lam Research in Q2 2021 and has held it in 20 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Evermay Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.